Lingotto

Lingotto is an investment management company owned by Exor N.V. and launched by the Italian dynasty the Agnelli family. The company possesses a set of distinctive competitive edges that distinguish it in the market. One key strength lies in its unique investment strategies, which are complementary, differentiated, and unparalleled, providing a competitive advantage over its peers. Moreover, the company has fostered a culture of partnership, promoting autonomy and cooperation among its stakeholders. This collaborative approach not only enhances teamwork but also strengthens relationships within the organization. Another significant aspect of the company's operations is its unwavering commitment to accountability, integrity, and transparency, ensuring a high level of trust and reliability for its clients and partners.

Morgan Samet

Managing Partner and Co-Head @ Lingotto Innovation

11 past transactions

NEURA Robotics

Series B in 2025
NEURA Robotics specializes in the development of robotic assistants designed to enhance cognitive capabilities. These robotic systems are engineered to collaborate seamlessly with humans, adapting autonomously to environmental changes while executing tasks. NEURA Robotics aims to support a variety of industries, including medical technologies, home automation, and food production, by improving operational efficiency and accelerating production processes. Through their innovative approach, the company seeks to bridge the gap between human and robotic interaction, facilitating more effective and intuitive workflows across diverse settings.

Enveda Biosciences

Series C in 2024
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.

Tokamak Energy

Venture Round in 2024
Tokamak Energy Ltd is a private company based in Abingdon, United Kingdom, focused on the development of fusion power technology. Founded in 2009, the company specializes in creating compact and cost-effective fusion power devices, particularly through the use of spherical tokamaks. These innovative reactors are designed to achieve higher plasma pressure with reduced magnetic field requirements compared to traditional tokamaks. Tokamak Energy utilizes high-temperature superconducting magnets to enhance plasma control within its devices, thereby improving efficiency. The company's commitment to rapid innovation leverages advanced materials and technology, building on decades of scientific research. By aiming to develop commercial fusion power solutions, Tokamak Energy contributes to the pursuit of affordable and sustainable energy, addressing global energy security while minimizing environmental impact.

Aira

Series B in 2024
Aira operates as a clean energy-tech company that provides heat pumps and home energy-saving solutions. Aira aims to lower CO2 emissions from residential heating, reduce reliance on foreign gas, and decrease consumer energy bills. Aira speeds up the electrification of residential heating with smart clean energy technology, paving the way for the net zero future that consumers need.

Aira

Series A in 2023
Aira operates as a clean energy-tech company that provides heat pumps and home energy-saving solutions. Aira aims to lower CO2 emissions from residential heating, reduce reliance on foreign gas, and decrease consumer energy bills. Aira speeds up the electrification of residential heating with smart clean energy technology, paving the way for the net zero future that consumers need.

Tempus

Series G in 2023
Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

TVS Industrial & Logistics Parks

Secondary Market in 2023
TVS Industrial & Logistics Parks Private Limited specializes in the design and construction of industrial infrastructure, including warehouses and logistics parks. Established in 2005 and headquartered in Mumbai, India, the company operates across various strategic locations such as Ernakulam, Bhubaneswar, Chakan, Hosur, Chennai, Pune, and Kanchipuram. It offers a comprehensive range of services, including land acquisition, facility design, construction, and commissioning tailored to client needs. The company's logistics parks feature storage facilities, dormitory services, and container freight stations, supporting sectors such as e-commerce, retail, automotive, energy, and agriculture. Additionally, TVS Industrial & Logistics Parks provides integrated facilities management services and engineering, procurement, and construction (EPC) solutions, emphasizing advanced construction methodologies and sustainable design.

Indigo

Venture Round in 2023
Indigo is an agricultural technology company dedicated to enhancing the sustainability and productivity of agriculture through its expertise in plant microbiomes. By leveraging a database of genomic microbe information, Indigo identifies and applies beneficial microbes to crops, primarily through seed coatings. This approach not only helps optimize plant health and yields but also aims to improve farmer profitability. Additionally, Indigo is committed to addressing broader agricultural challenges by promoting practices that reduce reliance on water, nitrogen fertilizers, and pesticides. Through these innovations, Indigo seeks to better serve the needs of farmers and consumers alike, contributing to the capacity to feed a growing global population while fostering sustainable farming practices.

NEURA Robotics

Venture Round in 2023
NEURA Robotics specializes in the development of robotic assistants designed to enhance cognitive capabilities. These robotic systems are engineered to collaborate seamlessly with humans, adapting autonomously to environmental changes while executing tasks. NEURA Robotics aims to support a variety of industries, including medical technologies, home automation, and food production, by improving operational efficiency and accelerating production processes. Through their innovative approach, the company seeks to bridge the gap between human and robotic interaction, facilitating more effective and intuitive workflows across diverse settings.

Optalysys

Series A in 2023
Optalysys Inc. is a technology company specializing in the development and commercialization of optical coprocessors designed for artificial intelligence and deep learning applications. Founded in 2013 and based in Reno, Nevada, Optalysys leverages low-power laser light to perform processor-intensive tasks, such as convolution functions for image classification and recognition. Its optical systems are aimed at enhancing the performance of various applications, including autonomous vehicles, medical image analysis, and weather forecasting, all while significantly reducing energy consumption compared to traditional computing hardware. The company's innovative technology enables supercomputing capabilities on edge and mobile devices, enhances the efficiency of existing systems, and incorporates quantum secure encryption to protect sensitive data during processing.

Vivodyne

Vivodyne is a biotechnology company that specializes in developing an advanced automated robotic system aimed at discovering innovative drugs and cellular therapies. The company has created a microfluidic bioengineering platform that focuses on single-cell 4D phenomics, allowing for a detailed exploration of biological complexities. Its technology enables the cultivation of highly realistic human tissue models for drug discovery, incorporating an integrated confocal microscope. This platform not only accelerates the drug development process but also allows researchers to formulate tunable mixtures of compounds and cell therapies. Through its unique approach, Vivodyne seeks to advance the understanding of human health and facilitate the creation of effective treatments for various diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.